Pharmaceuticals, Biotechnology and Life Sciences
PALO ALTO, Calif.–(BUSINESS WIRE)–#biotech—Medable, Inc., the leading global platform for decentralized clinical trials, today announced $25 million in funding to…
TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the appointment of Dr. Geoff Cotton, MB BS, MBA to its Board of…
LOS ANGELES–(BUSINESS WIRE)–Myst Therapeutics (Myst), a preclinical stage biotechnology company focused on developing selected TIL-based autologous T cell (PuriT™) therapy…
− Highly Potent and Broadly Cross-Reactive RNAi Therapeutic Development Candidate Selected Only Three Months After Program Initiation − − Companies…
HALIFAX, Nova Scotia–(BUSINESS WIRE)–$IMV #AntibioticDeveloper–Appili Therapeutics Inc. (the “Company” or “Appili”), a biopharmaceutical company focused on anti-infective drug development, announced…
VIENNA, Va.–(BUSINESS WIRE)–CEL-SCI Corporation (NYSE American: CVM) announced today that it has been notified that it has reached the targeted…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ribon Therapeutics, a clinical-stage oncology company developing first-in-class therapeutics targeting stress response pathways, today announced that Victoria Richon,…
NEW YORK–(BUSINESS WIRE)–Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today…
Fully automated immunoassay kit designed to simplify and streamline busulfan therapeutic drug monitoring (TDM), potentially reducing turnaround time from hours…
Pivotal trial did not meet primary or secondary efficacy variables Newron will prioritize its Phase III development program of Evenamide…